Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy
Titel:
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy
Auteur:
Ahmed, K.A. Abuodeh, Y.A. Echevarria, M.I. Arrington, J.A. Stallworth, D.G. Hogue, C. Naghavi, A.O. Kim, S. Kim, Y. Patel, B.G. Sarangkasiri, S. Johnstone, P.A.S. Sahebjam, S. Khushalani, N.I. Forsyth, P.A. Harrison, L.B. Yu, M. Etame, A.B. Caudell, J.J.